← Back to Search

Group 1 Not an Ad Disclosure for Trust

N/A
Waitlist Available
Research Sponsored by University of Ontario Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured after 5-10 minutes of exposure to the social media post
Awards & highlights
No Placebo-Only Group

Summary

There is limited research to inform policies and guidelines related to disclosing conflicts of interest on social media by healthcare professionals, including Registered Dietitians (RDs). This trial investigates mock social media posts by an RD to examine the impact of varying forms of conflict-of-interest (COI) disclosures. The disclosures tested are based on the Canadian Ad Standards "Influencer Marketing Disclosure Guidelines" and are incorporated into recommendations established by the provincial dietetic regulatory bodies for RDs. Specific outcomes evaluated include the public's ability to identify a COI; trust in the RD; credibility of the RD; transparency of the social media post and; purchasing and consumption intentions of the product endorsed by an RD in the post.

Eligible Conditions
  • Trust
  • Nutritionist
  • Conflict of Interest
  • Trustworthiness
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured after 5-10 minutes of exposure to the social media post
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured after 5-10 minutes of exposure to the social media post for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Conflict of Interest
Secondary study objectives
Consumption Intentions
Credibility
Purchasing Intentions
+2 more
Other study objectives
Engagement with the post
Frequency
Healthfulness
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: Group 4 Basic + Paid Partnership + Image labelExperimental Treatment1 Intervention
Disclosure includes the same attributes as Group 3, with the addition of #ad appearing on the post image itself.
Group II: Group 3 Basic + Paid Partnership DisclosureExperimental Treatment1 Intervention
Disclosure includes a branded "paid partnership" in the header and a tag for the industry partner, @brandname and #ad immediately at the beginning of the post, and #ad and #sponsored at the bottom of the narrative body of the social media post.
Group III: Group 2 Basic DisclosureExperimental Treatment1 Intervention
Disclosure includes @brandname and #ad in the narrative body of the social media post.
Group IV: Group 1 Not an Ad DisclosureExperimental Treatment1 Intervention
Disclosure includes @brandname and #NotAnAd in the social media post narrative body.
Group V: ControlActive Control1 Intervention
No COI Disclosure (Control). Only @brandname is tagged in the social media post narrative body.

Find a Location

Who is running the clinical trial?

University of Ontario Institute of TechnologyLead Sponsor
8 Previous Clinical Trials
1,406 Total Patients Enrolled
~0 spots leftby Nov 2024